These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10213922)

  • 1. Detection of preoperative serum anti-p53 antibodies in gastric cancer.
    Nakajima K; Suzuki T; Shimada H; Hayashi H; Takeda A; Ochiai T
    Tumour Biol; 1999; 20(3):147-52. PubMed ID: 10213922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
    Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of serum p53 antibody as a tumor marker in colorectal cancer patients.
    Ochiai H; Ohishi T; Osumi K; Tokuyama J; Urakami H; Seki S; Shimada A; Matsui A; Isobe Y; Murata Y; Endo T; Ishii Y; Hasegawa H; Matsumoto S; Kitagawa Y
    Surg Today; 2012 Jan; 42(2):164-8. PubMed ID: 22075664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients.
    Shimizu K; Ueda Y; Yamagishi H
    Gastric Cancer; 2005; 8(4):214-9. PubMed ID: 16328595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance.
    Würl P; Weigmann F; Meye A; Fittkau M; Rose U; Berger D; Rath FW; Dralle H; Taubert H
    Scand J Gastroenterol; 1997 Nov; 32(11):1147-51. PubMed ID: 9399397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
    Tokunaga R; Sakamoto Y; Nakagawa S; Yoshida N; Baba H
    Surg Today; 2017 May; 47(5):636-642. PubMed ID: 28062920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of serum p53 antibody levels in patients after curative resection for colorectal cancer.
    Kawahara H; Watanabe K; Enomoto H; Toyama Y; Akiba T; Yanaga K
    Anticancer Res; 2013 May; 33(5):2221-5. PubMed ID: 23645779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusually high levels of serum p53 antibody in recurrent gastric cancer.
    Kunizaki M; Hamasaki K; Wakata K; Hidaka S; Nagayasu T; Kinoshita Y
    Clin J Gastroenterol; 2017 Dec; 10(6):503-507. PubMed ID: 28952039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutated p53 in tumors, mutant p53 and p53-specific antibodies in the circulation in patients with gastric cancer.
    Maeta M; Saito H; Oka S; Tsujitani S; Ikeguchi M; Kaibara N
    J Exp Clin Cancer Res; 2000 Dec; 19(4):489-95. PubMed ID: 11277328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade.
    Wu CW; Lin YY; Chen GD; Chi CW; Carbone DP; Chen JY
    Br J Cancer; 1999 May; 80(3-4):483-8. PubMed ID: 10408857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.
    Kunizaki M; Sawai T; Takeshita H; Tominaga T; Hidaka S; To K; Miyazaki T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2016 Aug; 36(8):4171-5. PubMed ID: 27466527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum anti-p53 antibodies in lung cancer: comparison with established tumor markers.
    Cioffi M; Vietri MT; Gazzerro P; Magnetta R; D'Auria A; Durante A; Nola E; Puca GA; Molinari AM
    Lung Cancer; 2001; 33(2-3):163-9. PubMed ID: 11551411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
    Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
    Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serum p53 antibody measurement in colorectal cancer: an examination of 1384 primary colorectal cancer patients.
    Yamaguchi T; Takii Y; Maruyama S
    Surg Today; 2014 Aug; 44(8):1529-35. PubMed ID: 23975589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Changes and Clinical Significance of Preoperative and Postoperative Serum CEA and CA19-9 in Gastric Cancer.
    Jing R; Cui M; Ju S; Pan S
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.